Zacks Research Predicts Weaker Earnings for HealthEquity

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Equities researchers at Zacks Research cut their Q3 2027 earnings per share estimates for shares of HealthEquity in a report released on Tuesday, June 24th. Zacks Research analyst R. Department now forecasts that the company will earn $0.88 per share for the quarter, down from their prior estimate of $0.91. The consensus estimate for HealthEquity's current full-year earnings is $2.32 per share.

Other research analysts have also issued research reports about the company. KeyCorp cut their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Raymond James Financial upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price objective for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Bank of America raised their price objective on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. JMP Securities raised their price objective on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, June 5th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $118.09.

HealthEquity Price Performance

Shares of HealthEquity stock traded up $0.02 during trading on Thursday, reaching $104.88. 958,705 shares of the stock traded hands, compared to its average volume of 855,203. The company has a market capitalization of $9.07 billion, a price-to-earnings ratio of 76.55, a P/E/G ratio of 1.61 and a beta of 0.49. The business has a fifty day simple moving average of $98.01 and a two-hundred day simple moving average of $98.02. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. HealthEquity has a 52-week low of $65.01 and a 52-week high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The firm had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter last year, the business posted $0.80 earnings per share.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president now owns 75,689 shares of the company's stock, valued at $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 304,581 shares of company stock valued at $33,664,018. Insiders own 1.50% of the company's stock.

Institutional Trading of HealthEquity

Several institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc bought a new stake in shares of HealthEquity during the first quarter valued at approximately $28,000. WPG Advisers LLC bought a new stake in shares of HealthEquity during the first quarter valued at approximately $28,000. Transce3nd LLC bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $29,000. Smartleaf Asset Management LLC raised its stake in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $39,000. Institutional investors own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.